Acarix Investor Relations Material
Latest events
Q1 2025
Acarix
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Acarix
Access all reports
Acarix AB is a Swedish medical technology company specializing in diagnostic solutions for coronary artery disease (CAD). Its flagship product, the CADScor System, uses sensitive acoustics and advanced algorithms to assess coronary blood flow, providing a rapid, non-invasive method for ruling out CAD in patients experiencing chest pain. The system is designed for use in clinical settings by healthcare professionals to help streamline the diagnosis process. The company is headquartered in Malmö, Sweden, and its shares are traded on the Nasdaq Stockholm.
Key slides for Acarix
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
ACARIX
Country
🇸🇪 Sweden